Theoretical and applied concepts of nanocarriers for the treatment of Parkinson's diseases
Parkinson's disease is a neurodegenerative disorder characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta region (SNpc) of the brain. Although, FDA-approved therapeutic agents are available for the treatment of Parkinson's disease. However, the per...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2023-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |